Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 7.

Journal Article

Goldkuhle, Marius, Bender, Ralf, Akl, Elie A., van Dalen, Elvira C., Nevitt, Sarah, Mustafa, Reem A., Guyatt, Gordon H., Trivella, Marialene, Djulbegovic, Benjamin, Schunemann, Holger, Cinquini, Michela, Kreuzberger, Nina ORCID: 0000-0001-8922-0488 and Skoetz, Nicole (2021). GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes-Study limitations due to censoring of participants with missing data in intervention studies. J. Clin. Epidemiol., 129. S. 126 - 138. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-5921

Peinemann, Frank ORCID: 0000-0002-4727-1313, Tushabe, Doreen A., van Dalen, Elvira C. and Berthold, Frank (2015). Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. Cochrane Database Syst Rev. (5). HOBOKEN: WILEY. ISSN 1361-6137

Peinemann, Frank, van Dalen, Elvira C., Enk, Heike and Berthold, Frank (2017). Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. Cochrane Database Syst Rev. (8). HOBOKEN: WILEY. ISSN 1361-6137

Peinemann, Frank, van Dalen, Elvira C., Enk, Heike and Tytgat, Godelieve A. M. (2019). Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation. Cochrane Database Syst Rev. (4). HOBOKEN: WILEY. ISSN 1361-6137

Peinemann, Frank ORCID: 0000-0002-4727-1313, van Dalen, Elvira C., Tushabe, Doreen A. and Berthold, Frank (2015). Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137

Skoetz, Nicole, Goldkuhle, Marius, Weigl, Aaron, Dwan, Kerry, Labonte, Valerie, Dahm, Philipp ORCID: 0000-0003-2819-2553, Meerpohl, Joerg J., Djulbegovic, Benjamin and van Dalen, Elvira C. (2019). Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviews. J. Clin. Epidemiol., 108. S. 1 - 10. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-5921

Skoetz, Nicole, Goldkuhle, Marius, van Dalen, Elvira C., Akl, Elie A., Trivella, Marialena, Mustafa, Reem A., Nowak, Artur, Dahm, Philipp, Schunemann, Holger and Bender, Ralf (2020). GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles. J. Clin. Epidemiol., 118. S. 124 - 132. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-5921

This list was generated on Wed Aug 17 04:17:57 2022 CEST.